ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Arena Pharmaceuticals, Inc. 

6166 Nancy Ridge Drive

San Diego  California  92121  U.S.A.
Phone: 858-453-7200 Fax: 858-453-7210


SEARCH JOBS


Industry
Biotechnology


Collaborations

Lexicon Genetics Incorporated 

Merck & Co.  Cardiovascular





 Company News
Arena Pharmaceuticals, Inc. (ARNA) Skimps On Data Disclosure From Weight-Loss Combo Study: Analyst 10/30/2014 6:39:56 AM
Arena Pharmaceuticals, Inc. (ARNA) Announces Third Quarter 2014 Conference Call And Webcast On Monday, November 3 10/27/2014 7:52:49 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce Presentation Of Lorcaserin Hcl Data At The American College Of Clinical Pharmacy Annual Meeting 10/13/2014 7:38:28 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce Publication Of Pooled Phase 3 Clinical Trial Analysis Of BELVIQ® (Lorcaserin Hcl) CIV In Postgraduate Medicine 10/10/2014 9:52:26 AM
Arena Pharmaceuticals, Inc. (ARNA) To Present At The NewsMakers In The Biotech Industry Conference 9/22/2014 8:32:09 AM
Arena Pharmaceuticals, Inc. (ARNA)' APD811 Granted Orphan Drug Status For Pulmonary Arterial Hypertension 9/3/2014 3:56:48 PM
Biotech Hiring Surge: Trends To Watch; Industry Tips From Arena Pharmaceuticals, Inc. (ARNA) 8/25/2014 3:19:23 AM
Arena Pharmaceuticals, Inc. (ARNA) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/1/2014 7:28:10 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce Publication Of Post-Hoc Analyses Of Lorcaserin Phase 3 Clinical Trial Results In Obesity 7/30/2014 8:22:26 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce BELVIQ® (lorcaserin HCl) CIV Nominated A Second Time For The Prix Galien Award In The Best Pharmaceutical Agent Category 7/29/2014 8:04:43 AM
12345678910...